3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
3
Leukoplakia, Oral
2
Insulin Resistance
2
Diabetes Mellitus
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
1
Sleep Apnea, Obstructive
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Metabolic Syndrome
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Head and Neck Neoplasms
1
Glucose Intolerance
1
Diabetes Mellitus, Type 2
1
Carotid Intimal Medial Thickness 1
1
Carcinoma, Squamous Cell
1
Interventions
Hydroxyurea
3
Bevacizumab
3
pembrolizumab
2
Imatinib Mesylate
2
Everolimus
2
vistusertib
1
vatalanib
1
pasireotide
1
fludarabine phosphate
1
fludarabine
1
arginyllysine
1
antineoplaston AS 2-1
1
antineoplaston A10
1
aldesleukin
1
Whole Body Imaging
1
Verapamil
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiosurgery
1
Proton Therapy
1
Nivolumab
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
HDAC-42
1
Fentanyl
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Meningioma
×
Pioglitazone
×
Clear all
No trials found.